FI66020C - Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2 - Google Patents

Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2 Download PDF

Info

Publication number
FI66020C
FI66020C FI782769A FI782769A FI66020C FI 66020 C FI66020 C FI 66020C FI 782769 A FI782769 A FI 782769A FI 782769 A FI782769 A FI 782769A FI 66020 C FI66020 C FI 66020C
Authority
FI
Finland
Prior art keywords
cells
glycoproteins
extract
vaccine
infected
Prior art date
Application number
FI782769A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI782769A (fi
FI66020B (fi
Inventor
Vivian Larson
Ernest Dale Lehman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI782769A publication Critical patent/FI782769A/fi
Application granted granted Critical
Publication of FI66020B publication Critical patent/FI66020B/fi
Publication of FI66020C publication Critical patent/FI66020C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI782769A 1977-09-19 1978-09-11 Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2 FI66020C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83459877A 1977-09-19 1977-09-19
US83459877 1977-09-19

Publications (3)

Publication Number Publication Date
FI782769A FI782769A (fi) 1979-03-20
FI66020B FI66020B (fi) 1984-04-30
FI66020C true FI66020C (fi) 1984-08-10

Family

ID=25267310

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782769A FI66020C (fi) 1977-09-19 1978-09-11 Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2

Country Status (9)

Country Link
EP (1) EP0001365B2 (no)
JP (1) JPS5484024A (no)
CA (1) CA1114294A (no)
DE (1) DE2862086D1 (no)
DK (1) DK411878A (no)
FI (1) FI66020C (no)
IE (1) IE47364B1 (no)
IT (1) IT1110864B (no)
NO (1) NO153692C (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
US5219567A (en) * 1982-03-24 1993-06-15 The University Of Birmingham Vaccine against herpes viruses
EP0089854B1 (en) * 1982-03-24 1988-12-07 The University Of Birmingham Vaccine against dna viruses
CA1201987A (en) * 1982-03-24 1986-03-18 Gordon R.B. Skinner Vaccine against dna viruses
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
EP0312164A1 (en) * 1987-10-16 1989-04-19 Merck & Co. Inc. Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells
US5081010A (en) * 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
DE4033446A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Impfstoffe gegen equine herpesviren und ihre herstellung
US5334503A (en) * 1991-10-08 1994-08-02 Eastman Kodak Company Test kit and method for the detection of microorganisms associated with periodontal diseases using surfactant mixture as extraction composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses

Also Published As

Publication number Publication date
IE47364B1 (en) 1984-03-07
EP0001365B2 (en) 1987-09-23
NO153692C (no) 1986-05-07
EP0001365A1 (en) 1979-04-04
JPS5484024A (en) 1979-07-04
IT7851116A0 (it) 1978-09-15
CA1114294A (en) 1981-12-15
DK411878A (da) 1979-03-20
IE781880L (en) 1979-03-19
EP0001365B1 (en) 1982-11-10
NO783143L (no) 1979-03-20
FI782769A (fi) 1979-03-20
IT1110864B (it) 1986-01-06
DE2862086D1 (en) 1982-12-16
NO153692B (no) 1986-01-27
FI66020B (fi) 1984-04-30

Similar Documents

Publication Publication Date Title
FI66020C (fi) Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4452734A (en) Herpes subunit vaccine
KR100703571B1 (ko) 인플루엔자에 대한 펩티드-기초 백신
KR100186783B1 (ko) 적혈구와 표면-결합된 항원을 포함하는 경구용 백신
Meignier et al. Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus
CN105906721B (zh) 一种水痘-带状疱疹病毒gB-gE-gH-gL融合蛋白、基因工程亚单位疫苗及制备方法
CN100387618C (zh) 无细胞百日咳疫苗和其制备方法
US4374127A (en) Herpes sub unit vaccine
Lin et al. Absence of M protein in a cell-associated subacute sclerosing panencephalitis virus
KR20200040899A (ko) 헨드라 및 니파 바이러스 ｇ 당단백질 면역원성 조성물
JP2002186494A (ja) 組換えワクシニアウイルス
CA1244766A (en) Herpes simplex virus subunit vaccine
US4317811A (en) Herpes simplex type 1 subunit vaccine
Kaaden et al. Vaccination against Marek's disease: Immunizing effect of purified turkey herpes virus and cellular membranes from infected cells
CN101370518A (zh) 免疫活性组合物
Klein et al. Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice
Klockmann et al. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine
Epstein Vaccination against Epstein-Barr virus: current progress and future strategies
CN110743007B (zh) 一种联合疫苗及其制备方法、应用
US4322404A (en) Process for the production of new mutants of herpes simplex virus type 1 and type 2
EP0413637A1 (en) Attenuated live hepatitis A vaccine (H2 Strain) and its method of preparation
WO2005014803A1 (ja) 西ナイルウイルスワクチン
US4540669A (en) Herpes simplex type I subunit vaccine
WO2003049683A2 (en) Use of parapox b2l protein to treat cancer and modify immune responses
GB2062463A (en) Babesiosis vaccine

Legal Events

Date Code Title Description
TC Name/ company changed in patent

Owner name: KONINKLIJKE PHILIPS ELECTRONICS N.V.

TC Name/ company changed in patent

Owner name: KONINKLIJKE PHILIPS ELECTRONICS N.V.

MM Patent lapsed

Owner name: MERCK & CO., INC.